Skip to main content

Table 3 Baseline Co-morbidities and Liver Decompensations of Cirrhosis Patients Admitted to UC Davis Health System, January 2013 to January 2018

From: Racial disparities of Black Americans hospitalized for decompensated liver cirrhosis

Characteristics

Whites

(NĀ =ā€‰241)

Hispanics

(NĀ =ā€‰106)

Blacks

(NĀ =ā€‰50)

API

(NĀ =ā€‰27)

Other

(NĀ =ā€‰39)

P value

Diabetes N (%)

80 (33.3)

40 (37.7)

22 (44.0)

19 (70.4)

17 (44.7)

0.004

Coronary artery disease (%)

65 (27.0)

25 (23.6)

27 (54.0)

6 (22.2)

5 (13.5)

0.0004

COPD (%)

50 (20.9)

14 (13.2)

13 (26.0)

4 (15.4)

4 (10.5)

0.17

Smoking (%)

165 (69.0)

67 (64.4)

37 (74.0)

15 (55.6)

29 (76.3)

0.34

Hepatic encephalopathy (%)

151 (62.9)

70 (66.0)

33 (66.0)

17 (63.0)

31 (79.5)

0.38

Gastro-esophageal varices (%)

96 (42.3)

61 (61.6)

20 (41.7)

14 (53.9)

19 (50.0)

0.02

Ascites (%)

163 (67.9)

65 (61.3)

30 (61.2)

17 (63.0)

25 (64.1)

0.74

Liver cancer (%)

2 (0.8)

1 (1.0)

1 (2.0)

2 (7.4)

1 (2.6)

0.09

Etiology of Liver Disease

Ā Ā Ā Ā Ā 

<ā€‰ 0.0001

ā€ƒHCV (%)

60 (25.0)

26 (24.5)

19 (38.0)

6 (22.2)

9 (23.1)

Ā 

ā€ƒAlcohol (%)

82 (34.2)

46 (43.4)

15 (30.0)

3 (11.1)

15 (38.5)

Ā 

ā€ƒHCVā€‰+ā€‰Alcohol (%)

36 (15.0)

15 (14.2)

5 (10.0)

0 (0.0)

7 (18.0)

Ā 

ā€ƒNASH (%)

24 (10.0)

2 (1.9)

0 (0.0)

5 (18.5)

4 (10.3)

Ā 

ā€ƒHBV (%)

3 (1.3)

0 (0.0)

1 (2.0)

7 (25.9)

0 (0.0)

Ā 

ā€ƒAutoimmune, PBC, PSC (%)

7 (2.9)

4 (3.8)

1 (2.0)

0 (0.0)

0 (0.0)

Ā 

ā€ƒUnknown, other (%)

28 (11.7)

13 (12.3)

9 (18.0)

6 (22.2)

4 (10.3)

Ā 
  1. API Asian and Pacific Islander, COPD Chronic obstructive pulmonary disease, HCV Hepatitis C Virus, NASH non-alcoholic steatohepatitis, PBC primary biliary cholangitis, PSC primary sclerosing cholangitis